https://www.selleckchem.com/pr....oducts/abc294640.htm
At a median follow-up of 14 months (range, 2-78 months), overall 5-year survival was 23.75% (mean survival 33.77 months, median survival 24 months). The 5-year survival for stages I-III was 100%, 26.25%, and 11.25%, respectively (P less then 0.001). Though perioperative chemotherapy has a role in gastric cancer, it is not the substitute for radical D2 gastrectomy which is still the gold standard treatment especially in high-volume centers. © Indian Association of Surgical Oncology 2019.Surgeons constantly try to achieve optimal surgic
Like
Comment
Share
